{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:04:36Z","timestamp":1790395476217,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,5,26]],"date-time":"2004-05-26T00:00:00Z","timestamp":1085529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1038\/sj.ejhg.5201184","type":"journal-article","created":{"date-parts":[[2004,5,26]],"date-time":"2004-05-26T03:05:40Z","timestamp":1085540740000},"page":"678-681","source":"Crossref","is-referenced-by-count":33,"title":["Remarkable variability in renal disease in a large Slovenian family with Fabry disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Franc","family":"Verovnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davorin","family":"Benko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Vujkovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor E","family":"Linthorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,5,26]]},"reference":[{"key":"BF5201184_CR1","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng ME : \u03b1-Galactosidase A deficiency: Fabry disease; in: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. New York: McGraw-Hill,; 2001, Vol 3: 8th edn. pp 3733\u20133774."},{"key":"BF5201184_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T et al: Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype. Kidney Int 2003; 64: 801\u2013807.","journal-title":"Kidney Int"},{"key":"BF5201184_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"ScheidtW von","year":"1991","unstructured":"von Scheidt W, Eng CM, Fitzmaurice TF et al: An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 1991; 324: 395\u2013399.","journal-title":"N Engl J Med"},{"key":"BF5201184_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/humu.1380030204","volume":"3","author":"CM Eng","year":"1994","unstructured":"Eng CM, Desnick RJ : Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat 1994; 3: 103\u2013111.","journal-title":"Hum Mutat"},{"key":"BF5201184_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1086\/345309","volume":"72","author":"D Blom","year":"2003","unstructured":"Blom D, Speijer D, Linthorst GE, Donker-Koopman WG, Strijland A, Aerts JM : Recombinant enzyme therapy for Fabry disease Absence of editing of human \u03b1-Galactosidase A mRNA. Am J Hum Genet. 2003; 72: 23\u201331.","journal-title":"Am J Hum Genet."},{"issue":"8","key":"BF5201184_CR6","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/ndt\/gfg194","volume":"18","author":"GE Linthorst","year":"2003","unstructured":"Linthorst GE, Hollak CEM, Korevaar JC, van Manen JG, Aerts JMFG, Boeschoten EW : \\{alpha\\}-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease. Nephrol Dial Transplant 2003; 18 (8): 1581\u20131584.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"BF5201184_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410400105","volume":"40","author":"P Mitsias","year":"1996","unstructured":"Mitsias P, Levine SR : Cerebrovascular complications of Fabry's disease. Ann Neurol 1996; 40 (1): 8\u201317.","journal-title":"Ann Neurol"},{"issue":"6","key":"BF5201184_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1161\/01.STR.17.6.1277","volume":"17","author":"T Nishizaki","year":"1986","unstructured":"Nishizaki T, Tamaki N, Takeda N, Shirakuni T, Kondoh T, Matsumoto S : Dolichoectatic basilar artery: a review of 23 cases. Stroke 1986; 17 (6): 1277\u20131281.","journal-title":"Stroke"},{"key":"BF5201184_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000060196","volume":"136","author":"C Whybra","year":"2001","unstructured":"Whybra C, Wendrich K, Ries M, Gal A, Beck M : Clinical manifestation in female Fabry disease patients. Contrib Nephrol 2001; 136: 245\u2013250.","journal-title":"Contrib Nephrol"},{"key":"BF5201184_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ajmg.1320100207","volume":"10","author":"KJ Sheth","year":"1981","unstructured":"Sheth KJ, Good TA, Murphy JV : Heterozygote detection in Fabry disease utilizing multiple enzyme activities. Am J Med Genet 1981; 10: 141\u2013146.","journal-title":"Am J Med Genet"},{"key":"BF5201184_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jmg.14.2.91","volume":"14","author":"MW Spence","year":"1977","unstructured":"Spence MW, Goldbloom AL, Burgess JK et al: Heterozygote detection in angiokeratoma corporis diffusum (Anderson\u2013Fabry disease). Studies on plasma, leucocytes, and hair follicles. J Med Genet 1977; 14: 91\u201399.","journal-title":"J Med Genet"},{"key":"BF5201184_CR12","first-page":"1186","volume":"53","author":"CM Eng","year":"1993","unstructured":"Eng CM, Resnick-Silverman LA, Niehaus DJ, Astrin KH, Desnick RJ : Nature frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet 1993; 53: 1186\u20131197.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"BF5201184_CR13","first-page":"343","volume":"1","author":"JM Tager","year":"1980","unstructured":"Tager JM, Hamers MN, Schram AW et al: An appraisal of human trials in enzyme replacement therapy of genetic diseases. Birth Defects Orig Artic Ser 1980; 1 (1): 343\u2013359.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"BF5201184_CR14","first-page":"227","volume":"48","author":"P Ashton-Prolla","year":"2000","unstructured":"Ashton-Prolla P, Tong B, Shabbeer J, Astrin KH, Eng CM, Desnick RJ : Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene genotype\/phenotype correlations in severely mildly affected hemizygotes heterozygotes. J Invest Med 2000; 48: 227\u2013235.","journal-title":"J Invest Med"},{"key":"BF5201184_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR et al: Safety efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 9\u201316.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5201184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201184","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5201184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T21:31:18Z","timestamp":1684359078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5201184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,26]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BF5201184"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5201184","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,26]]}}}